Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-14-016162
Filing Date
2014-04-01
Accepted
2014-04-01 15:32:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 116899
  Complete submission text file 0000000000-14-016162.txt   162218
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filed for) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 6770 Blank Checks